Suppression of pain-related behavior in two distinct rodent models of peripheral neuropathy by a homopolyarginine-conjugated CRMP2 peptide

Journal of Neurochemistry

Volumn 124, Issue 6, 2013, Pages 869-879

  Ju, Weina ^a,c   Li, Qi ^d   Allette, Yohance M ^a   Ripsch, Matthew S ^a   White, Fletcher A ^a   Khanna, Rajesh ^a,b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Sophia Therapeutics LLC   (United States)

^c JILIN UNIVERSITY   (China)

^d Basic Medical College   (China)

Author keywords

calcium imaging; CaV2.2; CRMP2; neuropathic pain; peptide inhibitor; polyarginine motif

Indexed keywords

2',3' DIDEOXYCYTIDINE DERIVATIVE; CALCIUM; CALCIUM CHANNEL N TYPE; COLLAPSIN RESPONSE MEDIATOR PROTEIN 2; FITC PROTEIN; FITC ST2 10 PROTEIN; GABAPENTIN; POLYARGININE; ST1 104 PROTEIN; ST2 104 PROTEIN; ST9 104 PROTEIN; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG; VOLTAGE GATED CALCIUM CHANNEL;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR CHANGE; CALCIUM TRANSPORT; CHRONIC PAIN; DEPOLARIZATION; FEMALE; NERVE INJURY; NOCICEPTION; NONHUMAN; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; RAT; SENSORY NERVE CELL; TIBIAL NERVE;

AMINO ACID SEQUENCE; ANIMALS; CELLS, CULTURED; DISEASE MODELS, ANIMAL; FEMALE; MICE; MOLECULAR SEQUENCE DATA; NERVE TISSUE PROTEINS; PAIN; PAIN MANAGEMENT; PEPTIDES; PERIPHERAL NERVOUS SYSTEM DISEASES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84874718658     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.12070     Document Type: Article

References (38)

1. Bhangoo S., Ren D., Miller R. J., et al,. (2007a) Delayed functional expression of neuronal chemokine receptors following focal nerve demyelination in the rat: a mechanism for the development of chronic sensitization of peripheral nociceptors. Mol. Pain 3, 38.
2. Bhangoo S. K., Ren D., Miller R. J., Chan D. M., Ripsch M. S., Weiss C., McGinnis C., and, White F. A., (2007b) CXCR4 chemokine receptor signaling mediates pain hypersensitivity in association with antiretroviral toxic neuropathy. Brain Behav. Immun. 21, 581-591.
3. Bordet T., and, Pruss R. M., (2009) Targeting neuroprotection as an alternative approach to preventing and treating neuropathic pain. Neurotherapeutics 6, 648-662.
4. Bowersox S. S., Singh T., Nadasdi L., Zukowska-Grojec Z., Valentino K., and, Hoffman B. B., (1992) Cardiovascular effects of omega-conopeptides in conscious rats: mechanisms of action. J. Cardiovasc. Pharmacol. 20, 756-764.
5. Brittain J. M., Chen L., Wilson S. M., et al,. (2011a) Neuroprotection against traumatic brain injury by a peptide derived from the collapsin response mediator protein 2 (CRMP2). J. Biol. Chem. 286, 37778-37792.
6. Brittain J. M., Duarte D. B., Wilson S. M., et al,. (2011b) Suppression of inflammatory and neuropathic pain by uncoupling CRMP-2 from the presynaptic Ca(2)(+) channel complex. Nat. Med. 17, 822-829.
7. Brittain J. M., Pan R., You H., Brustovetsky T., Brustovetsky N., Zamponi G. W., Lee W. H., and, Khanna R., (2012) Disruption of NMDAR-CRMP-2 signaling protects against focal cerebral ischemic damage in the rat middle cerebral artery occlusion model. Channels (Austin) 6, 52-59.
8. Caterina M. J., and, Julius D., (2001) The vanilloid receptor: a molecular gateway to the pain pathway. Annu. Rev. Neurosci. 24, 487-517.
9. Doggrell S. A., (2004) Intrathecal ziconotide for refractory pain. Expert Opin. Investig. Drugs 13, 875-877.
10. Duchardt F., Fotin-Mleczek M., Schwarz H., Fischer R., and, Brock R., (2007) A comprehensive model for the cellular uptake of cationic cell-penetrating peptides. Traffic 8, 848-866.
11. Eroglu C., Allen N. J., Susman M. W., et al,. (2009) Gabapentin receptor alpha2delta-1 is a neuronal thrombospondin receptor responsible for excitatory CNS synaptogenesis. Cell 139, 380-392.
12. Fuchs S. M., and, Raines R. T., (2004) Pathway for polyarginine entry into mammalian cells. Biochemistry 43, 2438-2444.
13. Fukata Y., Itoh T. J., Kimura T., et al,. (2002) CRMP-2 binds to tubulin heterodimers to promote microtubule assembly. Nat. Cell Biol. 4, 583-591.
14. Gee N. S., Brown J. P., Dissanayake V. U., Offord J., Thurlow R., and, Woodruff G. N., (1996) The novel anticonvulsant drug, gabapentin (Neurontin), binds to the alpha2delta subunit of a calcium channel. J. Biol. Chem. 271, 5768-5776.
15. Goldberg D. S., and, McGee S. J., (2011) Pain as a global public health priority. BMC Public Health 11, 770.
16. Greffrath W., Kirschstein T., Nawrath H., and, Treede R., (2001) Changes in cytosolic calcium in response to noxious heat and their relationship to vanilloid receptors in rat dorsal root ganglion neurons. Neuroscience 104, 539-550.
17. Harstall C., (2003) How prevalent is chronic pain? Pain Clin. Updates vol XI, 1-4.
18. Himmel H. M., Kiss T., Borvendeg S. J., Gillen C., and, Illes P., (2002) The arginine-rich hexapeptide R4W2 is a stereoselective antagonist at the vanilloid receptor 1: a Ca2+ imaging study in adult rat dorsal root ganglion neurons. J. Pharmacol. Exp. Ther. 301, 981-986.
19. Joseph E. K., Chen X., Khasar S. G., and, Levine J. D., (2004) Novel mechanism of enhanced nociception in a model of AIDS therapy-induced painful peripheral neuropathy in the rat. Pain 107, 147-158.
20. Malmberg A. B., and, Yaksh T. L., (1994) Voltage-sensitive calcium channels in spinal nociceptive processing: blockade of N- and P-type channels inhibits formalin-induced nociception. J. Neurosci. 14, 4882-4890.
21. Maneuf Y. P., Luo Z. D., and, Lee K., (2006) alpha2delta and the mechanism of action of gabapentin in the treatment of pain. Semin. Cell Dev. Biol. 17, 565-570.
22. Mitchell D. J., Kim D. T., Steinman L., Fathman C. G., and, Rothbard J. B., (2000) Polyarginine enters cells more efficiently than other polycationic homopolymers. J. Pept. Res. 56, 318-325.
23. Piekarz A. D., Due M. R., Khanna M., et al,. (2012) CRMP-2 peptide mediated decrease of high and low voltage-activated calcium channels, attenuation of nociceptor excitability, and anti-nociception in a model of AIDS therapy-induced painful peripheral neuropathy. Mol. Pain 8, 54.
24. Planells-Cases R., Aracil A., Merino J. M., Gallar J., Perez-Paya E., Belmonte C., Gonzalez-Ros J. M., and, Ferrer-Montiel A. V., (2000) Arginine-rich peptides are blockers of VR-1 channels with analgesic activity. FEBS Lett. 481, 131-136.
25. Ripsch M. S., Ballard C. J., Khanna M., Hurley J. H., White F. A., and, Khanna R., (2012) A peptide uncoupling CRMP-2 from the presynaptic Ca2 + channel complex demonstrate efficacy in animal models of migraine and AIDS therapy-induced neuropathy. Transl. Neurosci. 3, 1-8.
26. Saegusa H., Kurihara T., Zong S., Kazuno A., Matsuda Y., Nonaka T., Han W., Toriyama H., and, Tanabe T., (2001) Suppression of inflammatory and neuropathic pain symptoms in mice lacking the N-type Ca2 + channel. EMBO J. 20, 2349-2356.
27. Sarko D., Beijer B., Garcia B. R., Nothelfer E. M., Leotta K., Eisenhut M., Altmann A., Haberkorn U., and, Mier W., (2010) The pharmacokinetics of cell-penetrating peptides. Mol. Pharm. 7, 2224-2231.
28. Schmidtko A., Lotsch J., Freynhagen R., and, Geisslinger G., (2010) Ziconotide for treatment of severe chronic pain. Lancet 375, 1569-1577.
29. Suter M. R., Berta T., Gao Y. J., Decosterd I., and, Ji R. R., (2009) Large A-fiber activity is required for microglial proliferation and p38 MAPK activation in the spinal cord: different effects of resiniferatoxin and bupivacaine on spinal microglial changes after spared nerve injury. Mol. Pain 5 (53), 53.
30. Tunnemann G., Ter-Avetisyan G., Martin R. M., Stockl M., Herrmann A., and, Cardoso M. C., (2008) Live-cell analysis of cell penetration ability and toxicity of oligo-arginines. J. Pept. Sci. 14, 469-476.
31. Wang Y., Wilson S. M., Brittain J. M., Ripsch M. S., Salome C., Park K. D., White F. A., Khanna R., and, Kohn H., (2011) Merging structural motifs of functionalized amino acids and alpha-aminoamides results in novel anticonvulsant compounds with significant effects on slow and fast inactivation of voltage-gated sodium channels and in the treatment of neuropathic pain. ACS Chem. Neurosci. 2, 317-322.
32. Wender P. A., Mitchell D. J., Pattabiraman K., Pelkey E. T., Steinman L., and, Rothbard J. B., (2000) The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters. Proc. Natl Acad. Sci. USA 97, 13003-13008.
33. Wheeler D. G., Groth R. D., Ma H., Barrett C. F., Owen S. F., Safa P., and, Tsien R. W., (2012) Ca(V)1 and Ca(V)2 channels engage distinct modes of Ca(2+) signaling to control CREB-dependent gene expression. Cell 149, 1112-1124.
34. Wilson S. M., Brittain J. M., Piekarz A. D., et al,. (2011) Further insights into the antinociceptive potential of a peptide disrupting the N-type calcium channel-CRMP-2 signaling complex. Channels (Austin) 5, 449-456.
35. Wilson S. M., Schmutzler B. S., Brittain J. M., et al,. (2012a) Inhibition of transmitter release and attenuation of AIDS therapy-induced and tibial nerve injury-related painful peripheral neuropathy by novel synthetic Ca2+ channel peptides. J. Biol. Chem. 287, 35065-35077.
36. Wilson S. M., Xiong W., Wang Y., et al,. (2012b) Prevention of posttraumatic axon sprouting by blocking collapsin response mediator protein 2-mediated neurite outgrowth and tubulin polymerization. Neuroscience 210, 451-466.
37. Winter J., Dray A., Wood J. N., Yeats J. C., and, Bevan S., (1990) Cellular mechanism of action of resiniferatoxin: a potent sensory neuron excitotoxin. Brain Res. 520, 131-140.
38. Zhang Y., Wang Y. H., Zhang X. H., Ge H. Y., Arendt-Nielsen L., Shao J. M., and, Yue S. W., (2008) Proteomic analysis of differential proteins related to the neuropathic pain and neuroprotection in the dorsal root ganglion following its chronic compression in rats. Exp. Brain Res. 189, 199-209.